Department of Mechanical Engineering, Middle East Technical University, 06531, Ankara, Turkey.
School of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, Indiana, 47907, USA.
Pharm Res. 2023 Feb;40(2):501-523. doi: 10.1007/s11095-022-03298-8. Epub 2022 Jun 1.
Computational modeling of drug delivery is becoming an indispensable tool for advancing drug development pipeline, particularly in nanomedicine where a rational design strategy is ultimately sought. While numerous in silico models have been developed that can accurately describe nanoparticle interactions with the bioenvironment within prescribed length and time scales, predictive design of these drug carriers, dosages and treatment schemes will require advanced models that can simulate transport processes across multiple length and time scales from genomic to population levels. In order to address this problem, multiscale modeling efforts that integrate existing discrete and continuum modeling strategies have recently emerged. These multiscale approaches provide a promising direction for bottom-up in silico pipelines of drug design for delivery. However, there are remaining challenges in terms of model parametrization and validation in the presence of variability, introduced by multiple levels of heterogeneities in disease state. Parametrization based on physiologically relevant in vitro data from microphysiological systems as well as widespread adoption of uncertainty quantification and sensitivity analysis will help address these challenges.
药物输送的计算建模正成为推进药物开发管道的不可或缺的工具,特别是在纳米医学中,最终需要寻求合理的设计策略。虽然已经开发了许多可以在规定的长度和时间范围内准确描述纳米颗粒与生物环境相互作用的计算模型,但这些药物载体、剂量和治疗方案的预测设计需要能够模拟跨多个长度和时间尺度的传输过程的高级模型,从基因组到群体水平。为了解决这个问题,最近出现了整合现有离散和连续建模策略的多尺度建模工作。这些多尺度方法为药物设计输送的自下而上的计算管道提供了一个有前途的方向。然而,在存在疾病状态的多个层次的异质性所带来的变异性的情况下,在模型参数化和验证方面仍然存在挑战。基于微生理系统的生理相关体外数据的参数化以及广泛采用不确定性量化和敏感性分析将有助于解决这些挑战。